Miho Nara

897 total citations
31 papers, 613 citations indexed

About

Miho Nara is a scholar working on Hematology, Molecular Biology and Epidemiology. According to data from OpenAlex, Miho Nara has authored 31 papers receiving a total of 613 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Hematology, 6 papers in Molecular Biology and 6 papers in Epidemiology. Recurrent topics in Miho Nara's work include Chronic Myeloid Leukemia Treatments (6 papers), Acute Myeloid Leukemia Research (5 papers) and Acute Lymphoblastic Leukemia research (5 papers). Miho Nara is often cited by papers focused on Chronic Myeloid Leukemia Treatments (6 papers), Acute Myeloid Leukemia Research (5 papers) and Acute Lymphoblastic Leukemia research (5 papers). Miho Nara collaborates with scholars based in Japan and United States. Miho Nara's co-authors include Kazuaki Teshima, Hiroyuki Tagawa, Naoto Takahashi, Kenichi Sawada, Junsuke Yamashita, Atsushi Watanabe, Yoshihiro Kameoka, Sho Ikeda, Keiko Iwamoto and Masaaki Kume and has published in prestigious journals such as Blood, PLoS ONE and Oncogene.

In The Last Decade

Miho Nara

26 papers receiving 612 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Miho Nara Japan 12 276 193 144 138 113 31 613
Michaël Loschi France 12 217 0.8× 127 0.7× 88 0.6× 335 2.4× 166 1.5× 37 626
Jeonghwan Youk South Korea 12 240 0.9× 118 0.6× 93 0.6× 34 0.2× 162 1.4× 40 506
Peter Simpson United Kingdom 9 212 0.8× 160 0.8× 138 1.0× 187 1.4× 80 0.7× 10 554
Ryosei Nishimura Japan 11 162 0.6× 47 0.2× 170 1.2× 279 2.0× 252 2.2× 37 625
Mohsen Navari Italy 13 176 0.6× 165 0.9× 25 0.2× 95 0.7× 225 2.0× 32 475
Gaosheng Huang China 13 152 0.6× 68 0.4× 29 0.2× 66 0.5× 122 1.1× 35 432
Hart S. Dengler United States 7 249 0.9× 49 0.3× 32 0.2× 448 3.2× 101 0.9× 7 666
Vikram R. Paralkar United States 11 454 1.6× 322 1.7× 106 0.7× 50 0.4× 56 0.5× 24 619
Merel C. M. Strik Netherlands 10 154 0.6× 92 0.5× 68 0.5× 195 1.4× 79 0.7× 10 446
Hirotoshi Sakaguchi Japan 13 312 1.1× 52 0.3× 442 3.1× 108 0.8× 65 0.6× 51 752

Countries citing papers authored by Miho Nara

Since Specialization
Citations

This map shows the geographic impact of Miho Nara's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Miho Nara with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Miho Nara more than expected).

Fields of papers citing papers by Miho Nara

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Miho Nara. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Miho Nara. The network helps show where Miho Nara may publish in the future.

Co-authorship network of co-authors of Miho Nara

This figure shows the co-authorship network connecting the top 25 collaborators of Miho Nara. A scholar is included among the top collaborators of Miho Nara based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Miho Nara. Miho Nara is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Abe, Ko, Sho Ikeda, Miho Nara, et al.. (2023). Hypoxia‐induced oxidative stress promotes therapy resistance via upregulation of heme oxygenase‐1 in multiple myeloma. Cancer Medicine. 12(8). 9709–9722. 9 indexed citations
3.
5.
Akamine, Yumiko, et al.. (2022). Effects of ABCB1 polymorphisms on the transport of ponatinib into the cerebrospinal fluid in Japanese Philadelphia chromosome‐positive acute lymphoblastic leukaemia patients. British Journal of Clinical Pharmacology. 89(5). 1695–1700. 3 indexed citations
6.
Kobayashi, Takahiro, Akihiro Kitadate, Tomoko Yoshioka, et al.. (2022). Safe administration and pharmacokinetic monitoring of crushed venetoclax tablets with posaconazole and clarithromycin via percutaneous endoscopic gastrostomy tube in a patient with acute myeloid leukemia. Cancer Chemotherapy and Pharmacology. 90(3). 279–284. 1 indexed citations
7.
Kurosawa, Saiko, Takuhiro Yamaguchi, Takehiko Mori, et al.. (2021). Prevalence of organ symptoms in allo-HCT survivors and their impact on work and daily life. 10(4). 172–182. 1 indexed citations
8.
Yanada, Masamitsu, Shuichi Ota, Miho Nara, et al.. (2021). Autologous hematopoietic cell transplantation during second or subsequent complete remission of acute promyelocytic leukemia: a prognostic factor analysis. Bone Marrow Transplantation. 57(1). 78–82. 5 indexed citations
9.
Takeda, Masahide, Shigeharu Ueki, Yohei Yamamoto, et al.. (2020). Hypereosinophilic syndrome with abundant Charcot-Leyden crystals in spleen and lymph nodes. Asia Pacific Allergy. 10(3). e24–e24. 9 indexed citations
10.
Kato, Motohiro, Hideki Nakasone, Nobuaki Nakano, et al.. (2019). Clinical course of autologous recovery with chromosomal abnormalities after allogeneic hematopoietic stem cell transplantation. Bone Marrow Transplantation. 55(6). 1023–1028. 2 indexed citations
11.
Sugita, Junichi, Toshihiro Miyamoto, Yasuhiko Shibasaki, et al.. (2018). Myeloablative and reduced-intensity conditioning in HLA-haploidentical peripheral blood stem cell transplantation using post-transplant cyclophosphamide. Bone Marrow Transplantation. 54(3). 432–441. 62 indexed citations
13.
Ikeda, Sho, Akihiro Kitadate, Miho Nara, et al.. (2016). Disruption of CCL20-CCR6 interaction inhibits metastasis of advanced cutaneous T-cell lymphoma. Oncotarget. 7(12). 13563–13574. 20 indexed citations
14.
Fujishima, Naohito, Masatomo Miura, Takenori Niioka, et al.. (2016). Effects of CYP3A5 polymorphism on the pharmacokinetics of a once-daily modified-release tacrolimus formulation and acute kidney injury in hematopoietic stem cell transplantation. Cancer Chemotherapy and Pharmacology. 78(1). 111–118. 14 indexed citations
15.
Nara, Miho, Kazuaki Teshima, Atsushi Watanabe, et al.. (2013). Bortezomib Reduces the Tumorigenicity of Multiple Myeloma via Downregulation of Upregulated Targets in Clonogenic Side Population Cells. PLoS ONE. 8(3). e56954–e56954. 46 indexed citations
16.
Teshima, Kazuaki, Sho Ikeda, Atsushi Watanabe, et al.. (2013). Microrna-150 Inhibits Tumor Invasion and Metastasis By Targeting The Chemokine Receptor CCR6 In Advanced Cutaneous T-Cell Lymphoma. Blood. 122(21). 4248–4248. 1 indexed citations
17.
Teshima, Kazuaki, Miho Nara, Atsushi Watanabe, et al.. (2013). Dysregulation of BMI1 and microRNA-16 collaborate to enhance an anti-apoptotic potential in the side population of refractory mantle cell lymphoma. Oncogene. 33(17). 2191–2203. 45 indexed citations
18.
Nara, Mizuho, Atsushi Komatsuda, Masumi Fujishima, et al.. (2011). Renal paradoxical embolism in a hypertensive young adult without acute ischemic symptoms. Clinical and Experimental Nephrology. 15(4). 582–585. 4 indexed citations
19.
Miura, Masatomo, Naoto Takahashi, Syu‐ichi Kanno, et al.. (2011). Drug interaction of (S)-warfarin, and not (R)-warfarin, with itraconazole in a hematopoietic stem cell transplant recipient. Clinica Chimica Acta. 412(21-22). 2002–2006. 9 indexed citations
20.
Watanabe, Atsushi, Hitoshi Tagawa, Junsuke Yamashita, et al.. (2011). The role of microRNA-150 as a tumor suppressor in malignant lymphoma. Leukemia. 25(8). 1324–1334. 137 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026